Molekule Group (FRA:9O6) Treasury Stock : €0.00 Mil (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Molekule Group Treasury Stock?

Treasury stock is the portion of shares that a company keeps in their own treasury. Molekule Group's treasury stock for the quarter that ended in Jun. 2023 was €0.00 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.

Molekule Group Treasury Stock Historical Data

The historical data trend for Molekule Group's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Molekule Group Treasury Stock Chart

Molekule Group Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Treasury Stock

Molekule Group Quarterly Data
	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Treasury Stock	Get a 7-Day Free Trial									-	-	-	-	-

Molekule Group Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.

Molekule Group (FRA:9O6) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Molekule Group Inc (FRA:9O6) » Definitions » Treasury Stock

Comparable Companies

Traded in Other Exchanges

MKULQ:USA

Address

10455 Riverside Drive, Palm Beach Gardens, FL, USA, 33410

Website

https://www.molekule.com

Molekule Group Inc is an interior space air purification technology company with an immediate objective of initiating full-scale commercialization of its high-performance interior air sterilization and disinfection products for the eradication of coronavirus and other harmful airborne pathogens. The Company was established to develop technology-driven, medical-grade air purification solutions for hospitals and other healthcare settings. Its air hygiene product, Purgo, is an FD medical device that provides continuous air filtration, sanitization, and supplemental ventilation solutions with technology that can be applied in any indoor space including in hospitals, offices, and even in elevators.

Molekule Group (FRA:9O6) Headlines

No Headlines